Nisa Investment Advisors LLC Has $140.37 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Nisa Investment Advisors LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 268,011 shares of the healthcare conglomerate's stock after purchasing an additional 3,541 shares during the quarter. UnitedHealth Group makes up 0.7% of Nisa Investment Advisors LLC's portfolio, making the stock its 16th largest holding. Nisa Investment Advisors LLC's holdings in UnitedHealth Group were worth $140,371,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of UNH. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $30,000. Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $41,000. Finally, Copia Wealth Management acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $42,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 1.2%

UnitedHealth Group stock traded down $3.76 during midday trading on Thursday, reaching $299.15. The stock had a trading volume of 11,314,114 shares, compared to its average volume of 7,662,255. The firm's fifty day simple moving average is $316.42 and its 200-day simple moving average is $442.28. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a market capitalization of $271.37 billion, a P/E ratio of 12.53, a price-to-earnings-growth ratio of 1.45 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.96%. UnitedHealth Group's payout ratio is 37.02%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on UNH shares. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. UBS Group decreased their price target on UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating on the stock in a report on Wednesday, June 25th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $415.00.

Insider Activity

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.